Prognostic Impact of Pretreatment Elevated and Normalized Carcinoembryonic Antigen Levels After Neoadjuvant Chemoradiotherapy in Resected Locally Advanced Rectal Cancer Patients

References

• Song WY, Zhang X, Zhang Q, Zhang PJ, Zhang R. Clinical value evaluation of serum markers for early diagnosis of colorectal cancer. World J Gastrointest Oncol. 2020;12:219–227. doi:10.4251/wjgo.v12.i2.21932104552
   PubMed Web of Science ®Google Scholar
• Baca B, Beart RW, Etzioni DA. Surveillance after colorectal cancer resection: a systematic review. Dis Colon Rectum. 2011;54:1036–1048. doi:10.1007/DCR.0b013e31820db36421730795
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv22–iv40. doi:10.1093/annonc/mdx22428881920
   PubMed Web of Science ®Google Scholar
• Colloca GA, Venturino A, Guarneri D. Carcinoembryonic antigen reduction after medical treatment in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2019;34:657–666. doi:10.1007/s00384-018-03230-w30671635
   PubMed Web of Science ®Google Scholar
• Schaap DP, de Valk KS, Deken MM, et al. Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Br J Surg. 2020;107:334–337. doi:10.1002/bjs.1152331960953
   PubMed Web of Science ®Google Scholar
• Cho WK, Choi DH, Park HC, et al. Elevated CEA is associated with worse survival in recurrent rectal cancer. Oncotarget. 2017;8:105936–105941. doi:10.18632/oncotarget.2251129285304
   PubMedGoogle Scholar
• Nicholson BD, Shinkins B, Pathiraja I, et al. Blood CEA levels for detecting recurrent colorectal cancer. Cochrane Database Syst Rev;2015:CD011134. doi:10.1002/14651858.CD011134.pub226661580
   PubMed Web of Science ®Google Scholar
• Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311:263–270. doi:10.1001/jama.2013.28571824430319
   PubMed Web of Science ®Google Scholar
• Yang KM, Park IJ, Kim CW, Roh SA, Cho DH, Kim JC. The prognostic significance and treatment modality for elevated pre- and postoperative serum CEA in colorectal cancer patients. Ann Surg Treat Res. 2016;91:165–171. doi:10.4174/astr.2016.91.4.16527757393
   PubMed Web of Science ®Google Scholar
• Woo J, Kim J, Park I, et al. Perioperative serum carcinoembryonic antigen ratio is a prognostic indicator in patients with stage II colorectal cancer. Ann Coloproctol. 2018;34:4–10. doi:10.3393/ac.2018.34.1.429535981
   PubMed Web of Science ®Google Scholar
• Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized Phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30:1926–1933. doi:10.1200/JCO.2011.40.183622529255
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Netowrk. NCCN Clinical Practice Guidelines in Oncology Rectal Cancer. Version 1; 2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf. Accessed May 04, 2021.
   Google Scholar
• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193. doi:10.3322/caac.2139528248415
   PubMed Web of Science ®Google Scholar
• Ryan ÉJ, O’Sullivan DP, Kelly ME, et al. Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer. Br J Surg. 2019;106:1298–1310. doi:10.1002/bjs.1122031216064
   PubMed Web of Science ®Google Scholar
• Gambacorta MA, Masciocchi C, Chiloiro G, et al. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiat Oncol. 2020;154:154–160. doi:10.1016/j.radonc.2020.09.026
   Web of Science ®Google Scholar
• Du D, Su Z, Wang D, Liu W, Wei Z. Optimal interval to surgery after neoadjuvant chemoradiotherapy in rectal cancer: a systematic review and meta-analysis. Clin Colorectal Cancer. 2018;17:13–24. doi:10.1016/j.clcc.2017.10.01229153429
   PubMed Web of Science ®Google Scholar
• Zhai Z, Zhang K, Wang C, et al. Adding three cycles of CAPOX after neoadjuvant chemoradiotherapy increases the rates of complete response for locally advanced rectal cancer. Curr Oncol. 2021;28:283–293. doi:10.3390/curroncol2801003333419188
   PubMed Web of Science ®Google Scholar
• Kim SY, Joo J, Kim TW, et al. A randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: KCSG CO 14-03. Int J Radiat Oncol Biol Phys. 2018;101:889–899. doi:10.1016/j.ijrobp.2018.04.01329976501
   PubMed Web of Science ®Google Scholar
• Seddik Y, Brahmi SA, Afqir S. Does adjuvant chemotherapy for locally advanced resectable rectal cancer treated with neoadjuvant chemoradiotherapy have an impact on survival? A single moroccan institute retrospective study. Gulf J Oncolog. 2019;1:29–32.31242979
   PubMedGoogle Scholar
• Chung MJ, Lee JH, Lee JH, et al. Adjuvant chemotherapy in rectal cancer patients treated with preoperative chemoradiation and total mesorectal excision: a multicenter and retrospective propensity-score matching study. Int J Radiat Oncol Biol Phys. 2019;103:438–448. doi:10.1016/j.ijrobp.2018.09.01630244158
   PubMed Web of Science ®Google Scholar
• Bregni G, Akin Telli T, Camera S, et al. Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice. Cancer Treat Rev. 2020;83:101948. doi:10.1016/j.ctrv.2019.10194831955069
   PubMed Web of Science ®Google Scholar
• Kim CH, Huh JW, Yeom SS, Kim HR, Kim YJ. Predictive value of serum and tissue carcinoembryonic antigens for radiologic response and oncologic outcome of rectal cancer. Pathol Res Pract. 2020;216:152834. doi:10.1016/j.prp.2020.15283432001055
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Shida D, Tanabe T, et al. Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer. Cancer Med. 2020;9:653–662. doi:10.1002/cam4.275831799750
   PubMed Web of Science ®Google Scholar
• Restivo A, Delrio P, Deidda S, et al. Predictors of early distant relapse in rectal cancer patients submitted to preoperative chemoradiotherapy. Oncol Res Treat. 2020;43:146–152.32036373
   PubMed Web of Science ®Google Scholar
• Cai D, Huang ZH, Yu HC, et al. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer. World J Gastroenterol. 2019;25:4945–4958. doi:10.3748/wjg.v25.i33.494531543685
   PubMed Web of Science ®Google Scholar
• Wu S, Gu W. Association of T stage and serum CEA levels in determining survival of rectal cancer. Front Med. 2019;6:270. doi:10.3389/fmed.2019.00270
   Web of Science ®Google Scholar
• Song J, Huang X, Chen Z, et al. Predictive value of carcinoembryonic antigen and carbohydrate antigen 19-9 related to downstaging to stage 0-I after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Cancer Manag Res. 2018;10:3101–3108. doi:10.2147/CMAR.S16641730214303
   PubMed Web of Science ®Google Scholar
• Perez RO, Sao Juliao GP, Habr-Gama A, et al. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer. Dis Colon Rectum. 2009;52:1137–1143. doi:10.1007/DCR.0b013e31819ef76b19581858
   PubMed Web of Science ®Google Scholar
• Jang NY, Kang SB, Kim DW, et al. The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer. Dis Colon Rectum. 2011;54:245–252. doi:10.1007/DCR.0b013e3181fcee6821228676
   PubMed Web of Science ®Google Scholar
• Huh JW, Yun SH, Kim SH, et al. Prognostic role of carcinoembryonic antigen level after preoperative chemoradiotherapy in patients with rectal cancer. J Gastrointest Surg. 2018;22:1772–1778. doi:10.1007/s11605-018-3815-929845570
   PubMed Web of Science ®Google Scholar